Gene · 64422
Papers3,097
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,097
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Genetic Analysis of the Promoters of the ATG16L1 and ATG5 Genes Associated with Sporadic Parkinson's Disease. | Genes (Basel) | 2023 | 38136993 | PubTator, text mining | PubMed |
| Membrane Proteins and Membrane Curvature: Mutual Interactions and a Perspective on Disease Treatments. | Biomolecules | 2023 | 38136643 | PubTator, text mining | PubMed |
| Xenophagy as a Strategy for Mycobacterium leprae Elimination during Type 1 or Type 2 Leprosy Reactions: A Systematic Review. | Pathogens | 2023 | 38133338 | PubTator, text mining | PubMed |
| Autophagy as a dual-faced host response to viral infections. | Front Cell Infect Microbiol | 2023 | 38125906 | PubTator, text mining | PubMed |
| Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer. | J Ovarian Res | 2023 | 38115063 | PubTator, text mining | PubMed |
| Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making. | Sci Rep | 2023 | 38114725 | PubTator, text mining | PubMed |
| Ferritinophagy: research advance and clinical significance in cancers. | Cell Death Discov | 2023 | 38110359 | PubTator, text mining | PubMed |
| TMP269, a small molecule inhibitor of class IIa HDAC, suppresses RABV replication in vitro. | Front Microbiol | 2023 | 38107853 | PubTator, text mining | PubMed |
| Atg7 senses ATP levels and regulates AKT1-PDCD4 phosphorylation-ubiquitination axis to promote survival during metabolic stress. | Commun Biol | 2023 | 38081915 | PubTator, text mining | PubMed |
| The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges. | Stem Cell Res Ther | 2023 | 38072976 | PubTator, text mining | PubMed |
| Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies. | Mol Cancer | 2023 | 38071322 | PubTator, text mining | PubMed |
| Discovery of a Small-Molecule Modulator of the Autophagy-Lysosome Pathway That Targets Lamin A/C and LAMP1, Induces Autophagic Flux, and Affects Lysosome Positioning in Neurons. | ACS Chem Neurosci | 2023 | 38069806 | PubTator, text mining | PubMed |
| Effects of a N-Maleimide-derivatized Phosphatidylethanolamine on the Architecture and Properties of Lipid Bilayers. | Int J Mol Sci | 2023 | 38068893 | PubTator, text mining | PubMed |
| The Potential of Glycyrrhiza from "Medicine Food Homology" in the Fight against Digestive System Tumors. | Molecules | 2023 | 38067451 | PubTator, text mining | PubMed |
| The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. | Front Genet | 2023 | 38028615 | PubTator, text mining | PubMed |
| USF1 modulates transcription and cellular functions by regulating multiple transcription factors in Huh7 cells. | Oncol Lett | 2023 | 38020298 | PubTator, text mining | PubMed |
| Antidepressants as Autophagy Modulators for Cancer Therapy. | Molecules | 2023 | 38005316 | PubTator, text mining | PubMed |
| Encystation and Stress Responses under the Control of Ubiquitin-like Proteins in Pathogenic Amoebae. | Microorganisms | 2023 | 38004682 | PubTator, text mining | PubMed |
| Silencing GmATG7 Leads to Accelerated Senescence and Enhanced Disease Resistance in Soybean. | Int J Mol Sci | 2023 | 38003698 | PubTator, text mining | PubMed |
| Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions. | Int J Mol Sci | 2023 | 38003445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64422/papers?page=10